Thyrocare Technologies (THYROCARE) Stock Overview

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

THYROCARE Stock Information

Symbol

THYROCARE

Address

D/37-3, TTC Industrial AreaNavi Mumbai, 400703India

Founded

Trading hours

Website

https://www.thyrocare.com

Country

🇮🇳 India

Phone Number

91 22 4125 2525

Thyrocare Technologies (THYROCARE) Price Chart

Thyrocare Technologies Overview: Key Details and Summary

Stock data	2023	Change
Price	$10.34	N/A
Market Cap	$547.38M	N/A
Shares Outstanding	52.92M	0.06%
Employees	1.65K	N/A
Shareholder Equity	5.35B	1.64%

Valuation	2023	Change
P/E Ratio	0.85	N/A
P/S Ratio	8.73	N/A
P/B Ratio	0.10	N/A

Growth	2023	Change
Return on Equity	0.0014	N/A

Earnings	2023	Change
Revenue	$62.71M	N/A
Earnings	$7.66M	N/A
EPS	12.14	N/A
Earnings Yield	1.17	N/A
Gross Margin	0.6901	N/A
Operating Margin	0.1607	N/A
Net income margin	0.1222	N/A

Financial Strength	2023	Change
Total Assets	$75.34M	N/A
Total Debt	$2.78M	N/A
Cash on Hand	$16.68M	N/A
Debt to Equity	0.0022	18.29%
Cash to Debt	$6.01	-10.41%
Current Ratio	$3.54	-15.41%